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ABSTRACT
In this study, maghemite (γ-Fe2O3) as magnetic nanoparticles (MNPs) material was coated by ceramic materials, 
calcium silicate (CaSiO3) with different concentrations to suit the medical treatment needed. Different concentration 
was studied to assess the optimal parameter and ability to maintain post-coated superparamagnetic properties of 
γ-Fe2O3.  Concentration of CaSiO3 coated on γ-Fe2O3 was prepared with 3 parameters, 97:3, 95:5, and 93:7% w/w, 
respectively. Magnetic properties of CaSiO3-γ-Fe2O3 were characterized by VSM proceeded with a bioactive study 
analyzed with FESEM and FTIR after simulated body fluid immersion for 5 days at 37±1ºC. CaSiO3-γ-Fe2O3 with 
concentration 95:5% w/w exhibit the highest magnetization makes it the most optimum with the average coercivity is 
1.6G. FESEM analysis illustrates that the existence of the apatite layer after 5 days of simulated body fluid (SBF) 
immersion on CaSiO3-γ-Fe2O3 coating sample, which confirmed the bioactive properties. Therefore, CaSiO3-γ-Fe2O3 
concentration at ratio 95:5% w/w can be a promising new biomaterial candidate to be applied in the medical field. 
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ABSTRAK
Dalam kajian ini, magemit (γ-Fe2O3) sebagai bahan nanozarah magnetik (MNPs) disalut oleh bahan seramik iaitu 
kalsium silikat (CaSiO3) dengan kepekatan yang berbeza untuk memenuhi keperluan rawatan perubatan. Kepekatan 
yang berbeza dikaji untuk menentukan parameter yang ideal dan keupayaan untuk mengekalkan sifat superparamagnetik 
yang dimiliki oleh γ-Fe2O3 selepas proses salutan. Kepekatan CaSiO3 menyalut kepada γ-Fe2O3 disediakan dengan 3 
parameter yang berbeza, 97:3% w/w, 95:5% w/w dan 93:7% w/w. Sifat magnetik CaSiO3-γ-Fe2O3 dicirikan oleh VSM 
kemudiannya diteruskan dengan kajian sifat bioaktif yang dianalisis menggunakan FESEM dan FTIR selepas 
direndamkan ke dalam larutan simulasi badan (SBF) selama hari pada 37 ± 1ºC. CaSiO3-γ-Fe2O3 dengan kepekatan 
95:5% w/w menunjukkan nilai magnetisasi tertinggi menjadikannya parameter paling optimum dengan purata koersiviti 
ialah 1.6G. Analisis FESEM menunjukkan kehadiran lapisan apatit selepas 5 hari rendaman SBF pada sampel CaSiO3-
γ-Fe2O3 mengesahkan sifat bioaktif yang dimiliki. Oleh itu, kepekatan CaSiO3-γ-Fe2O3 pada nisbah 95:5% w/w 
mempunyai potensi untuk dijadikan calon biobahan yang baru untuk diaplikasikan dalam bidang perubatan.
Kata kunci: Bioaktif; magemit; salutan kalsium silikat; superparamagnetik
INTRODUCTION
Ceramic materials have been researched by scientists for 
a variety of purposes and have been commonly used in 
different fields. In vitro studies have shown that ceramic 
materials have shown excellent bioactivity properties by 
the ability to form an apatite layer on their surface when 
in contact with the physiological fluids (Syed Nuzul et al. 
2016). Bioactivity studies were conducted using simulated 
body fluid (SBF) immersion, which was first invented by 
the Kokubos’s team and developed until ions concentration 
of SBF comparable to human blood plasma (Kokubo 1991; 
Ohtsuki et al. 1991). CaSiO3-based materials, particularly 
nanostructure, have high biocompatibility, biodegradability, 
bioactivity and high drug loading capacity making them 
ideal for medical used (Zhu et al. 2016).
Magnetic nanoparticles (MNPs) have an ultra-fine 
size, biocompatible and superparamagnetic properties 
within the nanoscale that is ideal for medicinal purposes. 
Small in size, magnetic nanoparticles (MNPs) materials 
can precisely penetrate to the target area and interact on a 
cellular (10-100 nm), subcellular (20-250 nm), protein 
(3-50 nm) or genetic scale (10-100 nm (Laurent et al. 
2008). Among MNPs materials iron oxide nanoparticles 
including magnetite (Fe3O4) and maghemite (γ-Fe2O3) were 
the most preferred due to low cost, less toxic and exhibit 
superparamagnetic properties such as high magnetic 
saturation moment and almost zero coercivity at room 
temperature (Sun et al. 2014). Superparamagnetic 
properties are particularly important for medical application 
such as for the transmission of drugs and genes transported 
to the targeted area due to its ability to respond to external 
magnetic fields (Burinaru et al. 2019). The synthesis of 
iron oxide nanoparticles has been developed intensely 
throughout the past decade. Numerous methods have been 
654
developed to synthesize MNPs including thermal 
decomposition, sol-gel, co-precipitation, hydrothermal 
synthesis and the oxidation of MNPs (Nazari et al. 2014).
Nevertheless, due to strong magnetic attraction 
between particles, iron oxide tends to agglomerate and is 
therefore not ideal for direct application in the bare surface 
conditions (Ali et al. 2016). The customization of surface 
coating on MNPs to the desired requirement can be 
accomplished by a surface modification which can enhance 
nanoparticle stabilization (Silva et al. 2016). Over the past 
years, surface modification of MNPs has been achieved 
by coating with biocompatible materials such as natural 
(dextran/ chitosan), synthetic polymers (PEG, PVA), gold 
and silica-based (Catalano et al. 2017) to improve their 
properties. Nevertheless, even without the external 
magnetic field applied, the surface modification on MNPs 
by polymers resulted in osteoinduction. However, a 
synthetic polymer such as PEG-coated also have some 
drawbacks, such as immunogenic activity can also create 
unwanted immune responses (Guerrini et al. 2018). Wu et 
al. (2010) stated that new combination of MNPs with 
ceramic materials could contribute to bone formation in 
both in vitro and in vivo, and could lead to a slightly high 
level of proliferation rate (Ngadiman 2015). Above all, as 
we have seen, there is less analysis paper and research of 
CaSiO3 as a coating material on γ-Fe2O3. CaSiO3 itself is a 
biocompatible ceramic material with excellent bioactivity 
and superior mechanical strength, making it a promising 
candidate as one of the coating materials on γ-Fe2O3. Past 
research papers indicated that CaSiO3 had shown promise 
as a clinically applied coating product over the years, such 
load-bearing implant coatings (Xie et al. 2014), titanium 
implant for hard tissue replacement (Buga et al. 2019) and 
modified Zn coating to facilitate osteogenic differentiation 
(Yu et al. 2017). Moreover, CaSiO3 had considered as 
potential candidates for artificial bone, when it was 
implanted into the human body and interacted with the 
surrounding bone by ion-exchange reaction (Liu et al. 
2008). 
Therefore, this paper attempts to study and present 
the ability of CaSiO3-γ-Fe2O3 coating by the in-vitro 
technique. In order to do that, performing surface 
alterations on γ-Fe2O3 using a new material called CaSiO3, 
the appropriate coating parameter is essential in order to 
ensure that the superparamagnetic properties can be 
preserved, which are especially crucial to fulfilling the 
medical needs in order to reduce side effect to patients. 
Since it has the potential to be controlled in the absence 
of an external magnetic field, exhibit superior 
biocompatibility and the size drops within 50-180 nm 
(Allaker & Yuan 2019; Menon et al. 2017). In this study, 
biomaterial was developed by the synthesizing of CaSiO3 
and γ-Fe2O3 manually with less polluting and low-cost 
reagents, following by a surface modification on γ-Fe2O3 
using a new potential coating material which is CaSiO3. 
Research was conducted with 3 concentrations CaSiO3 to 
γ-Fe2O3, 93:7% w/w, 95:5% w/w, and 97:3% w/w, 
respectively. Magnetic properties of CaSiO3-γ-Fe2O3 is a 
prior study before proceeding to the bioactivity study. 
Preliminary bioactivity study was conducted in SBF 
immersion for 5 days to study the growth of apatite 
formation. 
MATERIALS AND METHODS
PREPARATION OF CaSiO3-γ-Fe2O3
Nano-structured CaSiO3 was synthesized by adding of 
calcium nitrate tetrahydrate (Ca (NO3)2.4H2O 99% purity) 
to tetraethyl orthosilicate (TEOS 99% purity) using the 
sol-gel method. The homogeneous solution obtained from 
CaSiO3 was sealed and undergoes an ageing process at 
50°C for 24 h, followed by opening the seal and drying in 
the oven for the next 24 h at 110°C. The dried gels obtained 
were moved into an alumina crucible and sintered at 950°C 
for 2 h.
Maghemite nanoparticle (γ-Fe2O3) was synthesized 
by mixing ferrous chloride (FeCl2) and ferric chloride 
(FeCl3) at room temperature with ratio Fe
2+/Fe3+ = ½. Ten 
mL of 1M HCl was added to prevent oxidation of Fe2+ and 
precipitation of Fe3+. Afterwards, 20 mL of sodium 
hydroxide (NaOH) was dissolved into the solutions of 
mixture Fe2+/Fe3+ salts with continuous stirring resulting 
in a black precipitate. The black precipitation collected 
was diluted with deionized water to a volume of 200 mL 
and was oxidized under aeration where the solution was 
boiled while exposed to air for one hour at 95°C. The 
oxidation process resulted in the change of colour from 
black to brown. The γ-Fe2O3 saturated suspension was 
washed with deionized water and centrifuged four times 
to remove residue and isolate γ-Fe2O3 suspension and 
unwanted solution. Finally, γ-Fe2O3 decantation was dried 
at 40°C for 2 days. CaSiO3-γ-Fe2O3 coating was conducted 
using covalent bonding method with citric acid as a binder. 
Then, CaSiO3-γ-Fe2O3 was milled by a ball mill at 300 rpm 
for 15 min (Table 1). 
simuBIOACTIVE STUDY
Cylindrical samples of CaSiO3- γ-Fe2O3 powder is prepared 
by pressing the paste into the Teflon mould with a height 
of 12 mm and a diameter of 6 mm. Samples have been 
immersed in SBF to study the formation of apatite. Later 
the SBF solution was removed and then the samples were 
immersed in acetone for 2 h and rinsed with deionized (DI) 
water. Samples were dried in a desiccator for 24 h. SBF 
solution was prepared according to Kokubo’s method. 700 
mL of DI water was measured and poured into a 1L beaker 
while heating to 36.5±1.0°C with continuous stirring. 
Sodium chloride, sodium hydrogen carbonate, potassium 
chloride, di-potassium hydrogen phosphate trihydrate, 
magnesium chloride hexahydrate, calcium chloride, and 
sodium sulfate were dissolved one by one into DI water. 
With the addition of the final reagent, tris-hydroxymethyl 
aminomethane as buffer agent was added slowly into the 
solution to avoid the sudden increase of pH value and the 
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SBF solution would become a little turbid and have to stir 
constantly to obtain a clear solution. Finally, the pH value 
of the SBF solution will be adjusted to 7.4 @ 36.5°C by 
adding hydrochloric acid slowly for the SBF solution able 
to imitate human blood plasma perfectly (Kokubo 1991).
RESULTS AND DISCUSSION
Magnetic properties of pure γ-Fe2O3 and CaSiO3 coating 
on γ-Fe2O3 with ratio 97:3% w/w, 95:5% w/w and 93:7% 
w/w were measured using Vibrating Sample Magnetometer 
(VSM) at room temperature. Based on VSM analysis, 
superparamagnetic properties of nanomaterials can be 
proved with a single magnetic domain, exhibit negligible 
hysteresis loss and passes through its origin and above all, 
superparamagnetic properties verified the nano-size of the 
particles (Gopal & Joe 2017). According to Figure 1 (pure 
γ-Fe2O3) and Figure 2 (CaSiO3-γ-Fe2O3) coated with 
different ratios 97:3 % w/w, 95:5% w/w and 93:7 % w/w, 
both figures show magnetization curves indicating 
superparamagnetic properties of the nanoparticles 
(Khodabakhshi & Bahari 2017).
Pure γ-Fe2O3 displayed magnetization 48.88 emu/g 
lower than the corresponding bulk 74 emu/g (Shokrollahi 
2017) with coercivity value (Hc) 0.7G. In the past 
experiment reported that 31.18 emu/g magnetization of 
γ-Fe2O3 nanoparticles produced by chemical co-
precipitation at room temperature has been proved and 
achieved (Nurdin et al. 2014). Although all the samples 
exhibited superparamagnetic properties, with zero 
coercivity and remanence, CaSiO3-γ-Fe2O3-2 (95:5% w/w) 
show the highest magnetization with 20.97 emu/g. The 
coercivity of sample CaSiO3-γ-Fe2O3 (95:5% w/w) nearest 
to zero with 0.4G considered the ideal sample compare to 
the other ratios after the surface alteration since zero 
coercivity was the most favours to be controlled by external 
field particularly for a medical purpose (Wu et al. 2010). 
The agglomeration of γ-Fe2O3 can be minimized by coating 
and preserving the superparamagnetic properties makes 
them desirable to further applied for medicinal purposes. 
Subsequently, the appropriate amount of CaSiO3 added to 
γ-Fe2O3 s had a strong influence on the behaviour of the 
magnetic properties. Superparamagnetic properties are 
essential for medical purposes because, by demonstrating 
that particular behaviour, drugs can be quickly delivered 
and induced at precisely the specified time by self-heating, 
and can migrate along the field of attraction in the capillary 
blood system (Ali et al. 2016). Also, with surface alteration 
on γ-Fe2O3 by CaSiO3, the high aggregation proneness of 
γ-Fe2O3 may decrease, surface oxidation exposure can be 
protected, and blood circulation time may increase (Matos 
et al. 2019). 
Superparamagnetic properties functioning in the 
medicinal field by tracking the tumour cells as they can 
be identified with Magnetic Resonance Imaging (MRI) 
and destroy them by releasing drugs or magnetic, 
diagnosing and further monitoring early stages of 
endothelial inflammation, one of the early symptoms of 
cardiovascular diseases. Above all, superparamagnetic 
properties are injectable into tumour region, however, 
following this, not only cancerous cell would be 
destroyed, even the healthy cells could be affected 
(Dulińska-Litewka et al. 2019). Thus, in order to prevent 
and minimize the damage to the surrounding healthy cells, 
biocompatible CaSiO3-γ-Fe2O3 coating was performed 
wi th  app rop r i a t e  pa rame te r  wh i l e  ensu r ing 
superparamagnetic properties were maintained, the 
aggregation of γ-Fe2O3 decreased and the CaSiO3-γ-Fe2O3 
coating remained stable for prolonged usage. 
Theoretically, with the increasing saturation 
magnetization, the size of nanoparticles then will be 
decreased. 95:5% w/w ratio demonstrated the highest 
magnetization curves, with the smallest particle size among 
other ratios (93:7% w/w, 97:3% w/w). The results obtained 
from VSM analysis of CaSiO3-γ-Fe2O3 with ratio 95:5% 
w/w are in accordance to the study conducted by Ngadiman 
et al. (2015) which reported that the optimum parameter 
of γ-Fe2O3 nanoparticles was 5% w/w for tissue engineering 
scaffold. It could be therefore summed up that in this study, 
CaSiO3-γ-Fe2O3 with ratio 95:5% w/w has the potential for 
medical application. Hence, CaSiO3-γ-Fe2O3 with ratio 
95:5% w/w was chosen to proceed evaluated in vitro study 
by immersion into SBF solution containing ion 
concentrations nearest to human blood plasma. The 
bioactivity of the sample was examined by the formation 
of an apatite layer on the surface of CaSiO3-γ-Fe2O3. The 
sample was immersed in SBF for 5 days for preliminary 
bioactive study. 
For comparison of the bioactive study, CaSiO3-γ-Fe2O3 
sample without SBF and 5 days immersion were analyzed 
using Field Emission Scanning Electron Magnetometer 
(FESEM) and Fourier-Transform Infrared Spectroscopy 
(FTIR). Whereas, Figure 3 shows VSM analysis of CaSiO3-
γ-Fe2O3 in a physiochemical fluid of SBF immersion after 
TABLE 1. The parameters of CaSiO3 added to γ-Fe2O3 during the coating process
Sample Concentration of CaSiO3 (% w/w) Concentration of γ-Fe2O3 (% w/w)
Pure CaSiO3 100 0
CaSiO3-γ-Fe2O3-1 97 3
CaSiO3-γ-Fe2O3-2 95 5
CaSiO3-γ-Fe2O3-3 93 7
Pure γ-Fe2O3 0 100
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1, 3, and 5 days to predicted superparamagnetic behaviour 
prior in-vivo used. Analysis displayed the magnetization 
saturation was decreased along with the immersion period. 
After 5 days SBF immersion, magnetization was dropping 
to 0.21 emu/g. The previous finding stated that magnetization 
value will be rising if coated-shell (CaSiO3) degraded first 
than γ-Fe2O3 (Rabel et al. 2019). The functional group of 
the interaction CaSiO3-γ-Fe2O3 was identified by FTIR. 
The spectrum shows the functional group exists in the 
sample without SBF (Figure 4(a)) and with 5 days of SBF 
immersion (Figure 4(b)). The absorption peak at 1630 cm-1 
identified as hydroxyl group (O-H) of water (Lee et al. 
2017). Meanwhile, peak at 882 cm-1 reported as pure 
γ-Fe2O3 and peak at 1370 cm-1, 1630 cm-1, 1409 cm-1 were 
owed to O-H bonding vibration. 
The peak in the range of 400 cm-1 to 800 cm-1 
corresponds to be the stretching of Fe-O bonds (Gopal & 
Joe 2017). However, based on FTIR analysis, the increasing 
M
ag
ne
ti
za
ti
on
 (
em
u/
g)
 
 
 
 
 
 
M
ag
ne
ti
za
ti
on
 (
em
u/
g)
 
 
Field (G) 
 
Ms: 48.88 emu/g 
Field (G) 
 
(a) 
(b) 
(c) 
(a) 93:7 % w/w 
(b) 95:5 % w/w  
(c) 97:3 % w/w 
30 
 
 
 
15 
 
 
 
0 
 
 
 
-15 
 
 
 
-30 
Ms: 20.97 emu/g 
FIGURE 1. Superparamagnetic properties of pure γ-Fe2O3 before coated by CaSiO3 through VSM analysis
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FIGURE 2. Magnetization curves through VSM analysis CaSiO3- γ-Fe2O3 (a) 93:7% w/w (b) 95:5% w/w and (c) 97:3% w/w
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sharp peak at 1024 cm-1 was identified for CaSiO3-γ-Fe2O3 
sample with 5 days of SBF immersion compared to sample 
without SBF immersion where this peak is corresponding 
to the presence of P-O group. The increasing intensity 
values of the P-O group is attributed to the reaction between 
phosphate ions (PO4
3-) and calcium ions (Ca2+) during the 
formation of the apatite layer (Ismail et al. 2016). 
Additionally, this peak will gradually increase with the 
more prolonged SBF immersion as it resulted from the 
growing of the apatite layer.
In previous work, researchers have a high interest in 
calcium silicate as a coating material due to its’s ability to 
increase chemical stability in a physiological environment 
(Li et al. 2016). Morphology of CaSiO3-γ-Fe2O3 was 
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FIGURE 3. Magnetization curve of (a) day 1 SBF immersion, (b) day 3 SBF immersion and (c) day 5 SBF immersion
 
 
 
 
Field (G) 
 
M
ag
ne
ti
za
ti
on
 (
em
u/
g)
 
  
(a) 
(c) 
(b) 
(a) 1 Day 
(b) 3 Days 
(c) 5 Days 
Ms: 0.49 emu/g 
(a) 
(b) 
FIGURE 4. (a) CaSiO3-γ -Fe2O3without SBF immersion and (b) after 5 days SBF immersion
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analyzed by Field Emission Scanning Electron Microscopy 
(FESEM) analysis. Bioceramic materials will form 
crystalline calcium phosphate such as active biological 
hydroxyapatite layer (HA) on the surface of the material 
when immerses into the SBF solution which contained 
ions concentration similar to human blood plasma (Abdul 
Azam et al. 2018).
It was observed that, in Figure 5, regardless of the 
coating process conducted, the amount of iron (Fe+) has 
remained the same, as well the spherical shape of γ-Fe2O3. 
The CaSiO3- γ-Fe2O3 95:5% w/w with 5 days SBF 
immersion shown needle-type morphology as according 
to Damas et al. (2019) which indicates the absences of 
apatite layer.  Figure 5(a) shows a smooth surface unlike 
Figure 5(b) which shows rough needle look-alike structure 
which recognized as the apatite layer was formed due to 
Ca2+ ions release from CaSiO3 after interaction with SBF 
solution (Zamarron et al. 2009). The needle-like structures 
or apatite layer presence on CaSiO3-γ-Fe2O3’s surface will 
grow and becoming coral-like structures eventually more 
crystalline as the immersion period getting longer (Ismail 
et al. 2016).
The EDS spectra analysis shows that the Ca/P ratio 
for 5 days SBF soaking is about 3.35. The amount of Ca/P 
will further decrease with increasing immersion period and 
the value can reach approximately 1.67 after 10 days SBF 
immersion which conveyed ultimately a very thick apatite 
layer (Giannoulatou et al. 2018). EDS analysis demonstrates 
that the concentration of Fe ions was decreased after 
coating from 6.6 to 3.5 at% which can be assumed that 
CaSiO3 was successfully encapsulated γ-Fe 2O3 
nanoparticles. 
 
 
 
 
(a) 
(b) 
Needle 
2μm 
2μm 
FIGURE 5. FESEM images of CaSiO3 -γ -Fe2O3 (a) before soaking in SBF solution and (b) after 5 days soaking
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Therefore, it can be concluded that results obtained 
from FESEM analysis are in tallies with FTIR analysis. 
As the CaSiO3-γ-Fe2O3coating sample able to form apatite 
layer on its surface through morphology study and the peak 
of the P-O bond was increased after 5 days SBF immersion. 
Hence, through the bioactive study by immersed CaSiO3- 
γ-Fe2O3 into SBF solution, the ability of apatite to form on 
CaSiO3-γ-Fe2O3’s surface indicates that the coating process 
was successful by exhibiting good bioactivity.
CONCLUSION
Potential of CaSiO3-γ-Fe2O3 coating is considered to be 
successful with the ability to form apatite on the surface 
layer through in vitro study and proven good bioactivity. 
Superparamagnetic properties of γ-Fe2O3 can be preserved 
even after surface modification completed by CaSiO3 
proved that the presence of CaSiO3 did not affect the 
behaviour of γ-Fe2O3. All the data provided indicate that 
the concentration of CaSiO3 coating plays a fundamental 
role in ensuring the performance of γ-Fe2O3 accordingly. 
CaSiO3-γ-Fe2O3 with ratio 95:5% w/w demonstrates the 
most optimal compared to 93:7% w/w and 97:3% w/w 
with a better superparamagnetic property. We believe that 
the results obtained from this study, CaSiO3-γ-Fe2O3 
coating will be functioning at the upmost during medical 
treatment and can be bonded to the existed bone even 
shorter as artificial bone. The biocompatibility of CaSiO3-
γ-Fe2O3 can be further studied through cytotoxicity tests 
to enhance and strengthen the potential for medical 
treatments.
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